Cart
sales@molnova.com
TRPM8 antagonist 3
CAS No. 2102179-29-1
TRPM8 antagonist 3( —— )
Catalog No. M28848 CAS No. 2102179-29-1
TRPM8 antagonist 3 is a blocker of TRPM8 (IC50 = 11 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 205 | Get Quote |
|
| 10MG | 320 | Get Quote |
|
| 25MG | 531 | Get Quote |
|
| 50MG | 773 | Get Quote |
|
| 100MG | 1062 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTRPM8 antagonist 3
-
NoteResearch use only, not for human use.
-
Brief DescriptionTRPM8 antagonist 3 is a blocker of TRPM8 (IC50 = 11 nM).
-
DescriptionTRPM8 antagonist 3 is a blocker of TRPM8 (IC50 = 11 nM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorD3 receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2102179-29-1
-
Formula Weight292.315
-
Molecular FormulaC13H12N2O4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (85.53 mM)
-
SMILESO=C(C1=C(O)N=C(C2=CC=CC=C2O)S1)N3OCCC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Grundt P, et al. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor. J Med Chem. 2005 Feb 10;48(3):839-48.
molnova catalog
related products
-
GFB-8438
GFB-8438 is a potent and subtype selective inhibitor of TRPC5(IC50s of 0.18 and 0.29 μM of hTRPC5 and hTRPC4, respectively).
-
EIPA
EIPA (L593754, MH 12-43) is a TRPP3 channel inhibitor (IC50: 10.5 μM). It also inhibits Na+/H+-exchanger (NHE) and macropinocytosis.It is found that EIPA, benzamil, and phenamil rapidly and reversibly block Ca2+-activated TRPP3 channel activation at -50 mV, with IC50s of 143, 10.5, 1.1, and 0.14 μM, respectively.
-
Clemizole hydrochlor...
An H1 histamine receptor antagonist that substantially inhibits HCV replication by suppression of NS4B's RNA binding (IC50=24 nM) with little toxicity for the host cells.
